All News

ACOG Issues Consensus Guidance to Improve Pain Control During In-Office Gynecologic Procedures
May 16, 2025

Every patient should be offered evidence-based analgesia for pain management for in-office uterine and cervical procedures after shared, trauma-informed decision-making.

TikTok Videos Found Inaccurate on Birth Control but Tweet Volume Appears Authoritative on Endometrial Cancer
May 16, 2025

More than half of TikTok videos reviewed on hormonal birth control were patient-created and misleading while the majority of posts on endometrial cancer were by clinicians.

Majority of Pregnant Patients Accepted RSV Protection in Vaccine's First Season
May 16, 2025

Two-thirds of pregnant individuals opted for either maternal vaccination against RSV or for neonatal monoclonal antibody therapy and for other vaccines recommended in pregnancy.

ACOG 2025: Menopause and Vasomotor Symptoms Preview
May 16, 2025

A preview of sessions covering menopause and vasomotor symptoms during ACOG 2025 in Minneapolis, MN.

Low Uptake of Hereditary Cancer Screening Among Breast Cancer Survivors Highlights Missed Opportunities for Preventive Care
May 16, 2025

In a cancer survivorship clinic in urban New York, only one-quarter of long-term breast cancer survivors received genetic testing, contrary to current recommendations.

For Recurrent Bacterial Vaginosis, Simplified Once-Weekly Treatment Found More Effective than CDC-Recommended Regimen
May 16, 2025

Secnidazole granules reduced recurrence rates to 20% over a period of 28 weeks in a small prospective pilot study, outperforming cumbersome daily regimens.

Cannabis-Related ED Visits May Raise Dementia Risk: Daily Dose
May 16, 2025

Your daily dose of the clinical news you may have missed.

Evidence for Adverse Effects of High-Dose GC Treatment of Congenital Adrenal Hyperplasia Broadened, Deepened in New Literature Review
May 15, 2025

The most commonly reported adverse effects of high-dose glucocorticoid therapy were on bone health, cardiometabolic function, and height and growth.

Oral Gepotidacin Rivals Standard Gonorrhea Regimen in Trial: Daily Dose
May 15, 2025

Your daily dose of the clinical news you may have missed.